Bos Jacqueline M, van den Bemt Patricia M L A, Kievit Wietske, Pot Johan L W, Nagtegaal J Elsbeth, Wieringa André, van der Westerlaken Monique M L, van der Wilt Gert Jan, de Smet Peter A G M, Kramers Cornelis
Department of Clinical Pharmacy, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Department of Clinical Pharmacy, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Br J Clin Pharmacol. 2017 Mar;83(3):664-677. doi: 10.1111/bcp.13141. Epub 2016 Nov 10.
The P-REVIEW study was a prospective, multicenter, open intervention study, designed to determine whether a multifaceted intervention of educating the prescriber combined with medication review and pharmaceutical visits to the ward by the hospital pharmacist could lead to a reduction in drug-related complications among surgical patients.
A total of 6780 admissions of 5940 patients to surgical, urological and orthopaedic wards during the usual care period and 6484 admissions of 5711 patients during the intervention period were included. An educational programme covering pain management, antithrombotics, fluid and electrolyte management, prescription in case of renal insufficiency and antibiotics was developed. National and local hospital guidelines were included. Hospital pharmacists performed medication safety consultations, combining medication review of high-risk patients and a visit to the physician on the ward.
A significantly lower proportion of admissions with one or more clinically relevant, potentially preventable, drug-related problems (including death, temporary or sustained disability, increased length of hospital stay or readmission within 30 days) occurred in the intervention period (1.1% (73/6484) compared to the usual care period [1.6% (106/6780)] (P = 0.029). The relative risk (RR) was 0.72 (95% CI 0.53-0.97). Several types of drug-related problems occurred less frequently. Costs incurred as result of time spent on study-related activities were not different before and after the intervention.
The P-REVIEW study shows that education and support of the prescribing physician with respect to high-risk patients in surgical departments leads to a significant, clinically relevant benefit for patients without generating additional costs.
P-REVIEW研究是一项前瞻性、多中心、开放性干预研究,旨在确定由医院药剂师对开处方者进行教育并结合药物审查及到病房进行药学查房的多方面干预措施能否降低外科手术患者中与药物相关的并发症。
纳入了在常规护理期间外科、泌尿外科和骨科病房收治的5940例患者的6780次入院病例,以及干预期间5711例患者的6484次入院病例。制定了一个涵盖疼痛管理、抗血栓药物、液体和电解质管理、肾功能不全时的处方以及抗生素的教育计划。纳入了国家和当地医院的指南。医院药剂师进行了药物安全咨询,包括对高危患者的药物审查以及到病房拜访医生。
在干预期间,出现一种或多种具有临床相关性、潜在可预防的、与药物相关问题(包括死亡、暂时或持续残疾、住院时间延长或30天内再次入院)的入院病例比例显著降低(1.1%(73/6484),而常规护理期间为[1.6%(106/6780)](P = 0.029)。相对风险(RR)为0.72(95%CI 0.53 - 0.97)。几种类型的与药物相关问题发生频率较低。干预前后因参与研究相关活动所花费的时间产生的费用没有差异。
P-REVIEW研究表明,对外科高危患者的开处方医生进行教育和支持,可为患者带来显著的、具有临床相关性的益处,且不会产生额外费用。